Fig. 7From: Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptorThe influence of cetuximab pretreatment on [11C]EAI045 a biodistribution in xenografted mice (N = 16, n = 8/treatment), b tumor uptake, c tumor-to-blood ratio, and d tumor-to-muscle ratio in A549 (N = 8) and H1975 (N = 8) xenografted (n = 8/treatment) mice at 60 min p.iBack to article page